162 related articles for article (PubMed ID: 32521925)
1. Role of tumor suppressor protein p16 in patients with oral lichen planus.
Hadzi-Mihailovic M; Stanimirovic D; Pasoski B
J BUON; 2020; 25(2):1193-1198. PubMed ID: 32521925
[TBL] [Abstract][Full Text] [Related]
2. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
Jaafari-Ashkavandi Z; Aslani E
Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-137 promoter methylation in oral lichen planus and oral squamous cell carcinoma.
Dang J; Bian YQ; Sun JY; Chen F; Dong GY; Liu Q; Wang XW; Kjems J; Gao S; Wang QT
J Oral Pathol Med; 2013 Apr; 42(4):315-21. PubMed ID: 23121285
[TBL] [Abstract][Full Text] [Related]
5. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus.
Farshbaf A; Mohtasham N; Shamshiri AK; Khazaeni K; Aghaee-Bakhtiari SH; Arab F; Cheshomi M; Hassanabadi M; Mohajertehran F
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101806. PubMed ID: 38408642
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of MYC status in oral lichen planus in patients with progression to oral squamous cell carcinoma.
Segura S; Rozas-Muñoz E; Toll A; Martín-Ezquerra G; Masferrer E; Espinet B; Rodriguez M; Baró T; Barranco C; Pujol RM
Br J Dermatol; 2013 Jul; 169(1):106-14. PubMed ID: 23461699
[TBL] [Abstract][Full Text] [Related]
7. Implications on pathogenesis and risk of oral lichen planus neoplastic transformation: an ex-vivo retrospective immunohistochemical study.
Squarzanti DF; Cena T; Sorrentino R; Migliario M; Chiocchetti A; Rimondini L; Azzimonti B; Valente G
Histol Histopathol; 2019 Sep; 34(9):1015-1024. PubMed ID: 30907426
[TBL] [Abstract][Full Text] [Related]
8. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
9. Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus.
Németh CG; Röcken C; Siebert R; Wiltfang J; Ammerpohl O; Gassling V
PLoS One; 2019; 14(4):e0215055. PubMed ID: 30964915
[TBL] [Abstract][Full Text] [Related]
10. Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus.
Gholizadeh N; Emami Razavi A; Mohammadpour H; Tavakol F; Sheykhbahaei N
Mol Biol Rep; 2020 Feb; 47(2):1223-1232. PubMed ID: 31828562
[TBL] [Abstract][Full Text] [Related]
11. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
12. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature.
Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG
J BUON; 2011; 16(4):613-6. PubMed ID: 22331711
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus.
Hadzi-Mihailovic M; Raybaud H; Monteil R; Cakic S; Djuric M; Jankovic L
J BUON; 2010; 15(2):362-8. PubMed ID: 20658736
[TBL] [Abstract][Full Text] [Related]
14. In situ carcinoma developed over oral lichen planus: a case report with analysis of BUB3, p16, p53, Ki67 and SOX4 expression.
Rosa EA; Lia EN; Macedo SB; Amorim RF
J Appl Oral Sci; 2015; 23(4):442-7. PubMed ID: 26398519
[TBL] [Abstract][Full Text] [Related]
15. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy.
Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
J Oral Pathol Med; 2011 Apr; 40(4):294-9. PubMed ID: 21426400
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.
Shi P; Liu W; Zhou ZT; He QB; Jiang WW
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437
[TBL] [Abstract][Full Text] [Related]
19. Specific Deletion of p16
Ishida K; Tomita H; Kanayama T; Noguchi K; Niwa A; Kawaguchi M; Miyai M; Matsuo M; Imaizumi Y; Kato K; Hatano Y; Hirata A; Okada H; Shibata T; Hara A
Am J Pathol; 2020 Jun; 190(6):1332-1342. PubMed ID: 32194051
[TBL] [Abstract][Full Text] [Related]
20. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.
Lončar-Brzak B; Klobučar M; Veliki-Dalić I; Sabol I; Kraljević Pavelić S; Krušlin B; Mravak-Stipetić M
Clin Oral Investig; 2018 Mar; 22(2):1071-1082. PubMed ID: 28779221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
